Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

376 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phytoestrogens for menopausal vasomotor symptoms.
Lethaby A, Marjoribanks J, Kronenberg F, Roberts H, Eden J, Brown J. Lethaby A, et al. Among authors: eden j. Cochrane Database Syst Rev. 2013 Dec 10;2013(12):CD001395. doi: 10.1002/14651858.CD001395.pub4. Cochrane Database Syst Rev. 2013. PMID: 24323914 Free PMC article. Review.
Phytoestrogens and the menopause.
Eden J. Eden J. Baillieres Clin Endocrinol Metab. 1998 Dec;12(4):581-7. doi: 10.1016/s0950-351x(98)80005-0. Baillieres Clin Endocrinol Metab. 1998. PMID: 10384814 Review.
Phytoestrogens and the menopause.
Mackey R, Eden J. Mackey R, et al. Among authors: eden j. Climacteric. 1998 Dec;1(4):302-8. doi: 10.3109/13697139809085559. Climacteric. 1998. PMID: 11907938 Review.
Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.
Costello M, Shrestha B, Eden J, Sjoblom P, Johnson N. Costello M, et al. Among authors: eden j. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD005552. doi: 10.1002/14651858.CD005552.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2020 Aug 13;8:CD005552. doi: 10.1002/14651858.CD005552.pub3 PMID: 17253562 Updated. Review.
Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.
Kenemans P, Bundred NJ, Foidart JM, Kubista E, von Schoultz B, Sismondi P, Vassilopoulou-Sellin R, Yip CH, Egberts J, Mol-Arts M, Mulder R, van Os S, Beckmann MW; LIBERATE Study Group. Kenemans P, et al. Lancet Oncol. 2009 Feb;10(2):135-46. doi: 10.1016/S1470-2045(08)70341-3. Epub 2009 Jan 23. Lancet Oncol. 2009. PMID: 19167925 Free article. Clinical Trial.
376 results